Association of

Enas Ahmed Osman, Hanan Shawky, Rania Mohammed Abbas, Amna Ahmed Metwaly, Anas Hassan Ibrahim, Farida Mohamed Khanany

Abstract read

In one paragraph

Article in Indian journal of nephrology. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it

0cells of the map it votes in

1citing papers in PubMed

–field-weighted citation impact

1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

Association of the rs688 Polymorphism in the Gene Encoding Low-Density Lipoprotein Receptor in Bangladeshi Population With Coronary Artery Disease.Genetics research · 2026
Article

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Enas Ahmed OsmanDepartment of Clinical Chemistry, Theodor Bilharz Research Institute, Giza, Egypt.

Hanan ShawkyDepartment of Clinical Chemistry, Theodor Bilharz Research Institute, Giza, Egypt.

Rania Mohammed AbbasDepartment of Clinical Chemistry, Ain Shams University, Cairo, Egypt.

Amna Ahmed MetwalyDepartment of Intensive Care, Theodor Bilharz Research Institute, Giza, Egypt.

Anas Hassan IbrahimDepartment of Nephrology, Theodor Bilharz Research Institute, Giza, Egypt.

Farida Mohamed KhananyDepartment of Clinical Chemistry, Theodor Bilharz Research Institute, Giza, Egypt.ORCID https://orcid.org/0000-0001-9380-8612

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Background: The low-density lipoprotein receptor ( Materials and Methods: Polymorphism in this case-control study was genotyped using the TaqMan real-time polymerase chain reaction in a cohort of 100 CKD patients (Group I) and 100 healthy controls (Group II). We examined the Results: There was a significantly greater frequency of CT variant of LDL SNP rs688 in Group I than in Group II (p = 0.006). CT and TT genotypes were significantly higher in CKD patients with CVD, with odds ratios (ORs) (95% CI) of 4.3 (1.6-11.8, p = 0.004) and 7.6 (2.3-24.8, p = 0.001), respectively. Conclusion: SNP rs688 C>T detection in the

Indexed as

Cardiovascular diseaseChronic kidney diseaseLDLRRs688SNP

Identifiers

PMID39872263

DOI10.25259/IJN_33_2024

PMCPMC11763009

What OpenQuestion holds

Textmetadata

LicenceCC BY-NC-SA

Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.